Palomino Labs raises $15.1M in private placement; additional closings up to $30M

Palomino Laboratories Inc.

Sold 3,773,853 shares at $4.00/share in initial closing, raising $15.1M.
Additional closings up to $30M total may occur until April 30, 2026.
Laidlaw & Company acts as placement agent, earning 10%/5% fees and warrants.
Enters registration rights agreements to file resale registration statement.

item 1.01 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Palomino Laboratories Inc. issued 3,773,853 shares of common stock to certain accredited investors for $4.00 per Share.

Security: common stock
Shares: 3,773,853 shares
Purchaser: certain accredited investors
Consideration: $4.00 per Share

Exact text from the filing

On April 20, 2026, Palomino Laboratories Inc. (the “ Company ”) entered into subscription agreements (each a “ Subscription Agreement ”) with certain accredited investors and sold in an initial closing (the “ Initial Closing ”) of a private placement (the “ Offering ”) an aggregate of 3,773,853 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), for an aggregate purchase price of $15,095,412.00, at a purchase price of $4.00 per Share.

View on SEC.gov

Browse all equity issuances →

Palomino Laboratories Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-018963

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.